BBK's Privacy Expert Shares His View on the Positive Trend in Patient Trust in Clinical Trials

BBK's Privacy Expert Shares His View on the Positive Trend in Patient Trust in Clinical Trials

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

A recent survey shared in FiercePharma pointed to an upward trend in general public opinion of the pharmaceutical industry. But there is still work to be done.* 

Rob Laurens, Principal, Human Resources and Quality Assurance, credits much of this momentum to the work of everyone in the clinical R&D sector. 

The shift in the general public perception of clinical trials as a treatment option is reflected in BBK's day-to-day work. Sponsors and sites are adopting and embracing more patient-centric approaches within protocol design and supportive services. His overall message? Keep up the good work! 

Share your opinion. Leave a comment below. 


*U.S. trust in pharma ticks upward, but consumers still distrust the industry: survey FiercePharma 2019

Topics: Clinical Research, Big Data, Patient Experience, Pharma15 Live!, Vlog, Privacy